Why the study?
Does a nomogram for intravenous theophylline therapy improve the attainment of therapeutic serum concentrations in hospitalized patients?
Does a nomogram for intravenous theophylline therapy improve the attainment of therapeutic serum concentrations in hospitalized patients?
A nomogram for intravenous theophylline therapy effectively achieves therapeutic serum concentrations in hospitalized patients, facilitating dosing in complex patients with liver and cardiac disease.
Answers are grounded in this paper and cite their sources.
May aid theophylline dosing in complex hospitalized patients; hypothesis-generating and requires randomized outcome trials.
We evolved a nomogram for guiding and standardizing intravenous theophylline therapy in hospitalized patients. It provides rapid calculation of a loading dose based on body weight and previous therapy and a maintenance infusion rate related to three categories of expected metabolic activity. The guidelines were prospectively used in the treatment of 72 patients, mainly in a respiratory care unit. The nomogram was successfully used to attain near-steady-state serum concentrations in the therapeutic range of 8 to 20 mg/litre in 72% of patients, with only two patients outside of the range of 5 to 25 mg/litre. These guidelines facilitate initial theophylline dosage in older patients with liver and cardiac disease and provide a rational basis for interpreting serum concentration measurements and adjustment of drug therapy.
No takes yet. Share an insight, caveat, or question.
William J. Jusko (1977) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: